https://www.selleckchem.com/pr....oducts/rhps4-nsc7141
ycolytic rate and pH of muscle for a short time after slaughter.Bleomycin, a chemotherapy agent that inhibits synthesis of DNA, has been increasingly utilized in sclerotherapy for patients with vascular malformations. A serious long-term risk of intravenous bleomycin is dose-dependent interstitial pneumonitis. Little is known about absorption and circulating levels of bleomycin when used in sclerotherapy for patients with vascular malformations. This is an Institutional Review Board (IR-approved prospective study on patients r
Like
Comment
Share
